Then, we evaluated the correlation between the expression of CTHRC1 and the clinicopathological features (age, gender, race, clinical stage, histological, and TP53 mutation status) of COAD through the online cancer OMICS database of UALCAN. This evidence concerns the gene CTHRC1 and colon adenocarcinoma.